These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1424508)

  • 1. Persistence of the same Candida albicans strain despite fluconazole therapy. Documentation by pulsed-field gel electrophoresis.
    Blumberg HM; Hendershot EF; Lott TJ
    Diagn Microbiol Infect Dis; 1992 Aug; 15(6):545-7. PubMed ID: 1424508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluconazole failure in two cases of disseminated candidosis.
    Jahnson L; Chryssanthou E; Petrini B; Vikerfors T
    Scand J Infect Dis; 1995; 27(4):421-4. PubMed ID: 8658085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis by pulsed-field gel electrophoresis of Candida albicans that developed resistance during antifungal therapy.
    Mori T; Matsumura M; Oguri T
    Nihon Ishinkin Gakkai Zasshi; 1998; 39(4):229-33. PubMed ID: 9795269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999.
    Cheng MF; Yu KW; Tang RB; Fan YH; Yang YL; Hsieh KS; Ho M; Lo HJ
    Diagn Microbiol Infect Dis; 2004 Jan; 48(1):33-7. PubMed ID: 14761719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal activities of R-135853, a sordarin derivative, in experimental candidiasis in mice.
    Kamai Y; Kakuta M; Shibayama T; Fukuoka T; Kuwahara S
    Antimicrob Agents Chemother; 2005 Jan; 49(1):52-6. PubMed ID: 15616275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis.
    Pfaller MA; Rhine-Chalberg J; Redding SW; Smith J; Farinacci G; Fothergill AW; Rinaldi MG
    J Clin Microbiol; 1994 Jan; 32(1):59-64. PubMed ID: 7907345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fluconazole era: management of hematogenously disseminated candidiasis in the nonneutropenic patient.
    Kramer KM; Skaar DJ; Ackerman BH
    Pharmacotherapy; 1997; 17(3):538-48. PubMed ID: 9165556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.
    Nguyen MH; Peacock JE; Morris AJ; Tanner DC; Nguyen ML; Snydman DR; Wagener MM; Rinaldi MG; Yu VL
    Am J Med; 1996 Jun; 100(6):617-23. PubMed ID: 8678081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia.
    Nolte FS; Parkinson T; Falconer DJ; Dix S; Williams J; Gilmore C; Geller R; Wingard JR
    Antimicrob Agents Chemother; 1997 Jan; 41(1):196-9. PubMed ID: 8980781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breakthrough fungaemia in neonates and infants caused by Candida albicans and Candida parapsilosis susceptible to fluconazole in vitro.
    Krcmery V; Huttova M; Mateicka F; Laho L; Jurga L; Ondrusova A; Tarekova Z; Kralinsky K; Hanzen J; Liskova A; Mrazova M; Sabo A; Pisarcikova M; Kovacicova G; Chovancova D; Szovenyiova Z
    J Antimicrob Chemother; 2001 Oct; 48(4):521-5. PubMed ID: 11581231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitals.
    Colombo AL; Nakagawa Z; Valdetaro F; Branchini ML; Kussano EJ; Nucci M
    Med Mycol; 2003 Jun; 41(3):235-9. PubMed ID: 12964715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of breakthrough Candida bloodstream isolates correlates with daily and cumulative doses of fluconazole.
    Clancy CJ; Staley B; Nguyen MH
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3496-8. PubMed ID: 17005842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of nosocomial candidemia at a teaching hospital in Taiwan from 1981 to 2000: increased susceptibility of Candida species to fluconazole.
    Hsueh PR; Teng LJ; Yang PC; Ho SW; Luh KT
    Microb Drug Resist; 2002; 8(4):311-9. PubMed ID: 12523628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis.
    Redding S; Smith J; Farinacci G; Rinaldi M; Fothergill A; Rhine-Chalberg J; Pfaller M
    Clin Infect Dis; 1994 Feb; 18(2):240-2. PubMed ID: 8161633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
    Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
    Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and clinical significance of bloodstream infections caused by C albicans strains with reduced susceptibility to fluconazole.
    Muñoz P; Fernández-Turégano CP; Alcalá L; Rodríguez-Créixems M; Peláez T; Bouza E
    Diagn Microbiol Infect Dis; 2002 Oct; 44(2):163-7. PubMed ID: 12458123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of fluconazole and amphotericin B for treatment of experimental Candida endocarditis caused by non-C. albicans strains.
    Witt MD; Imhoff T; Li C; Bayer AS
    Antimicrob Agents Chemother; 1993 Sep; 37(9):2030-2. PubMed ID: 8239628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
    Shorr AF; Lazarus DR; Sherner JH; Jackson WL; Morrel M; Fraser VJ; Kollef MH
    Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community-acquired fungemia due to a multiple-azole-resistant strain of Candida tropicalis.
    Jandourek A; Brown P; Vazquez JA
    Clin Infect Dis; 1999 Dec; 29(6):1583-4. PubMed ID: 10585825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.